MPLX Q2: A Soft-Looking Quarter That Quietly De-Risked The Thesis

MPLX (MPLX) remains a Strong Buy, with reliable income and visible growth supported by robust project execution and strong demand. Distribution coverage remains healthy at ~1.3x, with a 12.5% distribution growth commitment now extended through 2026 and 2027. Recent distributable cash flow softness is attributed to timing and financing of growth projects, not structural weakness, with leverage at a manageable ~3.7x.